369 related articles for article (PubMed ID: 18855580)
1. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression.
Cosse JP; Michiels C
Anticancer Agents Med Chem; 2008 Oct; 8(7):790-7. PubMed ID: 18855580
[TBL] [Abstract][Full Text] [Related]
2. [Vascular perfusion as the origin of neoplasm resistance to radio- and chemotherapy].
Martinive P; Coucke PA
Rev Med Liege; 2010 Mar; 65(3):133-9. PubMed ID: 20411817
[TBL] [Abstract][Full Text] [Related]
3. Tumor hypoxia and cancer progression.
Zhou J; Schmid T; Schnitzer S; Brüne B
Cancer Lett; 2006 Jun; 237(1):10-21. PubMed ID: 16002209
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor.
Nordgren IK; Tavassoli A
Chem Soc Rev; 2011 Aug; 40(8):4307-17. PubMed ID: 21483947
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
6. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies.
Shannon AM; Bouchier-Hayes DJ; Condron CM; Toomey D
Cancer Treat Rev; 2003 Aug; 29(4):297-307. PubMed ID: 12927570
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia and cancer.
Brahimi-Horn MC; Chiche J; Pouysségur J
J Mol Med (Berl); 2007 Dec; 85(12):1301-7. PubMed ID: 18026916
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced modulation of apoptosis and BCL-2 family proteins in different cancer cell types.
Sermeus A; Genin M; Maincent A; Fransolet M; Notte A; Leclere L; Riquier H; Arnould T; Michiels C
PLoS One; 2012; 7(11):e47519. PubMed ID: 23139748
[TBL] [Abstract][Full Text] [Related]
9. A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance.
Yu JL; Coomber BL; Kerbel RS
Differentiation; 2002 Dec; 70(9-10):599-609. PubMed ID: 12492501
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives.
Otrock ZK; Hatoum HA; Awada AH; Ishak RS; Shamseddine AI
Crit Rev Oncol Hematol; 2009 May; 70(2):93-102. PubMed ID: 19186072
[TBL] [Abstract][Full Text] [Related]
11. Involvement of hypoxia-inducible factor 1 in human cancer.
Semenza GL
Intern Med; 2002 Feb; 41(2):79-83. PubMed ID: 11868612
[TBL] [Abstract][Full Text] [Related]
12. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
13. The ever-expanding role of HIF in tumour and stromal biology.
LaGory EL; Giaccia AJ
Nat Cell Biol; 2016 Apr; 18(4):356-65. PubMed ID: 27027486
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
Xia Y; Choi HK; Lee K
Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
[TBL] [Abstract][Full Text] [Related]
15. Microenvironmental and cellular consequences of altered blood flow in tumours.
Raghunand N; Gatenby RA; Gillies RJ
Br J Radiol; 2003; 76 Spec No 1():S11-22. PubMed ID: 15456710
[TBL] [Abstract][Full Text] [Related]
16. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
17. Cycling hypoxia: A key feature of the tumor microenvironment.
Michiels C; Tellier C; Feron O
Biochim Biophys Acta; 2016 Aug; 1866(1):76-86. PubMed ID: 27343712
[TBL] [Abstract][Full Text] [Related]
18. [Hypoxia and angiogenesis].
Simon JM
Bull Cancer; 2007 Jul; 94 Spec No():S160-5. PubMed ID: 17846000
[TBL] [Abstract][Full Text] [Related]
19. Tumour angiogenesis, anti-angiogenic therapy and chemotherapeutic resistance.
Mander KA; Finnie JW
Aust Vet J; 2018 Oct; 96(10):371-378. PubMed ID: 30255577
[TBL] [Abstract][Full Text] [Related]
20. The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression.
Amelio I; Melino G
Trends Biochem Sci; 2015 Aug; 40(8):425-34. PubMed ID: 26032560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
